A Brief Overview to TNF-a Inhibitors Therapy on Covid-19:
Functions Inside Cell Cascades
Volume 2 - Issue 1
Serife Yerlikaya*
-
Author Information
Open or Close
- Istanbul Medipol University, Regenerative and Restorative Medicine Research Center (REMER), Turkey
*Corresponding author:
Serife Yerlikaya, Istanbul Medipol University, Regenerative and Restorative Medicine Research Center
(REMER), Kavacik North Campus, Kavacik-Beykoz/ISTANBUL, Turkey
Received: May 25, 2020; Published: June 02, 2020
DOI: 10.32474/LOJPCR.2020.02.000129
Full Text
PDF
To view the Full Article Peer-reviewed Article PDF
Abstract
Viral Covid-19 has spreaded all over the World only in a few months and caused much deaths. Covid-19 is belong to coronavirus
family (called also SARS-CoV-2). Virus entry into cell occurs by unification with membrane receptors by releasing viral capsids or by
endocytosis. TNF inhibitors aim to block receptors that bind to intracellular pathways as soluble form or by membrane bounding.
Some TNF-α inhibitors have been used on severe Covid-19 patients nowadays.
Keywords: Receptor; Cell; Covid-19; İnhibitors
Abstract|
Introduction|
Tnf Inhibitors|
Conclusion|
Conflicts|
References|